9,203
Total Claims
$1.8M
Drug Cost
932
Beneficiaries
$1,901
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+25%
Cost per patient vs peers
$1,901 vs $1,524 avg
+22%
Brand preference vs peers
16.7% vs 13.7% avg
Brand vs Generic
83% generic
Brand: 1,536 claims · $1.6M
Generic: 7,667 claims · $201K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 730 | $853K |
| Sacubitril/Valsartan | 252 | $315K |
| Rivaroxaban | 128 | $164K |
| Alirocumab | 72 | $49K |
| Dapagliflozin Propanediol | 48 | $49K |
| Rosuvastatin Calcium | 1,116 | $30K |
| Evolocumab | 33 | $28K |
| Empagliflozin | 17 | $27K |
| Metoprolol Succinate | 892 | $19K |
| Ticagrelor | 22 | $17K |
| Atorvastatin Calcium | 746 | $13K |
| Diltiazem Hcl | 181 | $13K |
| Icosapent Ethyl | 16 | $11K |
| Icosapent Ethyl | 11 | $7,933 |
| Losartan Potassium | 482 | $7,440 |
Prescribing Profile
56
Unique Drugs
$1.4M
Patient Profile
77
Avg Age
47%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data